| MPP |
CD31, CD41, CD42, CD61, CD62P, CD63 |
33 Shah MD, Bergeron AL, Dong JF, Lopez JA. Flow cytometric measurement of
microparticles: pitfalls and protocol modifications. Platelets.
2008;19(5):365-72.
,
88 Faure V, Dou L, Sabatier F, Cerini C, Sampol J, Berland Y, et al.
Elevation of circulating endothelial microparticles in patients with chronic renal
failure. J Thromb Haemost. 2006;4(3):566-73.
,
1010 Toth B, Liebhardt S, Steinig K, Ditsch N, Rank A, Bauerfeind I, et al.
Platelet-derived microparticles and coagulation activation in breast cancer patients.
Thromb Haemost. 2008;100(4):663-9.
,
3939 Bernal-Mizrachi L, Jy W, Jimenez JJ, Pastor J, Mauro LM, Horstman LL, et
al. High levels of circulating endothelial microparticles in patients with acute
coronary syndromes. Am Heart J. 2003;145(6):962-70.
,
5858 Lins LC, França CN, Fonseca FA, Barbosa SP, Matos LN, Aguirre AC, et al.
Effects of ezetimibe on endothelial progenitor cells and microparticles in high-risk
patients. Cell Biochem Biophys. 2014;70(1):687-96.
,
6262 Montoro-Garcia S, Shantsila E, Hernández-Romero D, Jover E, Valdés M,
Marín F, et al. Small-size platelet microparticles trigger platelet and monocyte
functionality and modulate thrombogenesis via P-selectin. Br J Haematol.
2014;166(4):571-80.
|
| MPE |
CD31, CD51, CD54, CD62E,CD105, CD106, CD144, CD146,
E-selectina, VE-caderina |
88 Faure V, Dou L, Sabatier F, Cerini C, Sampol J, Berland Y, et al.
Elevation of circulating endothelial microparticles in patients with chronic renal
failure. J Thromb Haemost. 2006;4(3):566-73.
,
99 Joop K, Berckmans RJ, Nieuwland R, Berkhout J, Romijn FP, Hack CE, et
al. Microparticles from patients with multiple organ dysfunction syndrome and sepsis
support coagulation through multiple mechanisms. Thromb Haemost.
2001;85(5):810-20.
,
2323 Jimenez JJ, Jy W, Mauro LM, Horstman LL, Soderland C, Ahn YS.
Endothelial microparticles released in thrombotic thrombocytopenic purpura express
von Willebrand factor and markers of endothelial activation. Br J Haematol.
2003;123(5):896-902.
,
3434 Morel O, Pereira B, Averous G, Faure A, Jesel L, Germain P, et al.
Increased levels of procoagulant tissue factor-bearing microparticles within the
occluded coronary artery of patients with ST-segment elevation myocardial infarction:
role of endothelial damage and leukocyte activation. Atherosclerosis.
2009;204(2):636-41.
,
3636 Jeanneteau J, Hilbert P, Martinez MC, Tual-Chalot S, Tamareille S,
Furber A, et al. Microparticle release in remote ischemic conditioning mechanism. Am
J Physiol Heart Circ Physiol. 2012;303(7):H871-7.
,
3939 Bernal-Mizrachi L, Jy W, Jimenez JJ, Pastor J, Mauro LM, Horstman LL, et
al. High levels of circulating endothelial microparticles in patients with acute
coronary syndromes. Am Heart J. 2003;145(6):962-70.
,
4242 Tramontano AF, Lyubarova R, Tsiakos J, Palaia T, Deleon JR, Ragolia L.
Circulating endothelial microparticles in diabetes mellitus. Mediators Inflamm.
2010;2010:250476.
,
4343 Koga H, Sugiyama S, Kugiyama K, Watanabe K, Fukushima H, Tanaka T, et
al. Elevated levels of VE-cadherin-positive endothelial microparticles in patients
with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol.
2005;45(10):1622-30.
,
5858 Lins LC, França CN, Fonseca FA, Barbosa SP, Matos LN, Aguirre AC, et al.
Effects of ezetimibe on endothelial progenitor cells and microparticles in high-risk
patients. Cell Biochem Biophys. 2014;70(1):687-96.
59 Pinheiro LF, França CN, Izar MC, Barbosa SP, Bianco HT, Kasmas SH, et
al. Pharmacokinetic interactions between clopidogrel and rosuvastatin: effects on
vascular protection in subjects with coronary heart disease. Int J Cardiol.
2012;158(1):125-9.
60 França CN, Pinheiro LF, Izar MC, Brunialti MK, Salomão R, Bianco HT, et
al. Endothelial progenitor cell mobilization and platelet microparticle release are
influenced by clopidogrel plasma levels in stable coronary artery disease. Circ J.
2012;76(3):729-36.
-
6161 Morel O, Jesel L, Hugel B, Douchet MP, Zupan M, Chauvin M, et al.
Protective effects of vitamin C on endothelium damage and platelet activation during
myocardial infarction in patients with sustained generation of circulating
microparticles. J Thromb Haemost. 2003;1(1):171-7.
|
| MPM |
CD14, CD54 |
2828 Wen B, Combes V, Bonhoure A, Weksler BB, Couraud PO, Grau GE.
Endotoxin-induced monocytic microparticles have contrasting effects on endothelial
inflammatory responses. Plos One. 2014;9(3):e91597.
,
2929 Nieuwland R, Berckmans RJ, McGregor S, Böing AN, Romijn FP, Westendorp
RG, et al. Cellular origin and procoagulant properties of microparticles in
meningococcal sepsis. Blood. 2000;95(3):930-5.
,
3131 Hoyer FF, Giesen MK, França CN, Lütjohann D, Nickenig G, Werner N.
Monocytic microparticles promote atherogenesis by modulating inflammatory cells in
mice. J Cell Mol Med. 2012;16(11):2777-88.
|
